DONATE

Molecular Bionics

About

We are chemists, physicists, mathematicians, engineers, biologists who work alongside to design bionic units that mimic specific biological functions and/or introduce operations that do not exist in Nature. We apply a constructionist approach where we mimic biological complexity in the form of design principles to produce functional units from simple building blocks and their interactions.​ We called such an approach:  Molecular Bionics.

We are engaged in several activities involving the synthesis and characterisation of novel hierarchal materials whose properties are the result of the holistic combination of its components:

Molecular Engineering

We combine synthetic and supramolecular chemistry to tune inter/intramolecular interactions and self-assembly processes to form dynamic soft materials whose molecular, supramolecular and mesoscale structures are tuned and fit for the final application (pictured right: molecular engineering of nanoscopic structures starting from molecule passing to polymers and finally to supra molecular structures).

Physical Biology

Our materials are designed to interact with living systems and thus its biological activity is studied in high detail. We have developed and established new methodologies to study living systems and how synthetic materials interact with them combining holistically physical and life sciences (Physical Biology).

Synthetic Biology

Both know-hows are applied to study biological organisation and complexity creating synthetic surrogates that act as models, as well as to engineer novel sophisticated ways to interact with living organisms.

Somanautics

In analogy to medical bionics, where engineering and physical science converge to the design of replacement and/or enhancement of malfunctioning body parts, we take inspiration from viruses, trafficking vesicles and exosomes to apply molecular engineering to create nanoscopic carriers that can navigate the human body (Somanautics) with the final aim to improve drug delivery or create new diagnostic tools.


Visit our external website to find out more.

Staff

Projects

INTERNATIONAL GRANTSFINANCERPI
CheSSTag · Chemotactic Super-Selective Targeting of Gliomas (2020-2023)European Comission / ERC-CoGG. Battaglia
NATIONAL PROJECTSFINANCERPI
BrainPePN · Nanomedicinas de precisión que penetran el cerebro (2021-2024)MICIU / Retos investigación: Proyectos I+DG. Battaglia
FUNDRAISING PROJECTSFINANCERPI
A por la COVID-19 (2021-2022)IBEC / Faster Future 2020G. Battaglia

Publications

Equipment

  • State-of-the-art facilities for cell culture including 5 class A cell cabinets: one dedicated for LPS and RNAse free cell culture and one dedicated for infected tissues
  • Fluorescence Activated Cell Sorting (FACS)
  • Confocal microscope to perform live cell 4D imaging
  • Thermocycler
  • Real-time PCR
  • Automated Western Blot
  • Gel Permeation Chromatography
  • High-Performance Liquid Chromatography
  • Ultra Performance Liquid Chromatography equipped with fluorescence, UV/Vis and Infrared and light scattering detectors
  • Dynamic light scattering unit
  • Nanoparticle tracking analysis
  • UV and Fluorescence spectroscopy
  • Automated liquid handling units
  • Nanoparticle production units

Collaborations

  • Xavier Salvatella
    IRB Barcelona
  • Francesca Peiro
    Physics-University of Barcelona
  • Kostas Kostarellos
    Life Science- University of Manchester/ICN2
  • Giorgio Volpe
    Chemistry-UCL
  • Simona Parrinello
    Cancer Institute -UCL
  • Finn Werner
    Structural Biology -UCL
  • Nick Lane
    Evolutionary Biology -UCL
  • Darren Hargraves
    Pediatric Neuro-Oncology -UCL
  • Timothy McHugh
    Clinical Microbiology =UCL
  • Sebastian Brander
    Neurology -UCL
  • Joan Abbott
    Physiology -King’s College London
  • Molly Stevens
    Bioengineering -Imperial College London
  • Stefano Angioletti-Uberti
    Materials Science -Imperial College London
  • Ricardo Sapienza
    Physics -Imperial College London
  • Daan Frenkel
    Chemisty-University of Cambridge
  • Charlotte Williams
    Chemistry -University of Oxford
  • Francesco Gervasio
    Pharmacology -University of Geneve/UCL, UK
  • Francesco Stellacci
    Bionegineering -EPFL Switzerland
  • Tambet Tessalu
    Cancer Biology -University of Tartu (Estonia)/ Sanford Burnham Prebys Medical Discovery Institute
  • Darrel Irvine
    Bioengineering -MIT
  • Xiaohe Tian
    Life Sciences University of Anhui
  • Yupeng Tian
    Chemistry University of Anhui
  • Lei Luo
    Pharmacy -Southwest University, China
  • Kai Luo
    HuaXi hospital Sichuan University
  • Darren Hargrave
    Great Ormond Street Hospital, UCLH London
  • Sebastian Brander
    Queen Square National Centre for Neurology, UCLH London

News

Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.

The IBEC and West China Hospital hold their third joint conference on precision medicine in Barcelona

Barcelona hosted the third IBEC-WCH Precision Medicine Conference this week, an event that further strengthened the strategic alliance between the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital of Sichuan University (WCHSU). The Chinese delegation visited Spain from 26 to 29 November, taking part in a busy schedule of scientific and institutional activities and exchanges between the two centres.

A study led by IBEC has won the 3rd Vanguardia de la Ciencia 2025 Prize. The research, led by Samuel Sánchez Ordoñez and with Meritxell Serra-Casablanca as lead author, proposes an innovative bladder cancer therapy based on nanorobots loaded with radiopharmaceuticals. These nanorobots are capable of moving around the bladder using urine as a source of energy.

IBEC research takes third place in the 2025 Vanguardia de la Ciencia Awards

A study led by IBEC has won the 3rd Vanguardia de la Ciencia 2025 Prize. The research, led by Samuel Sánchez Ordoñez and with Meritxell Serra-Casablanca as lead author, proposes an innovative bladder cancer therapy based on nanorobots loaded with radiopharmaceuticals. These nanorobots are capable of moving around the bladder using urine as a source of energy.

Amaya Hernández-Vega, a senior researcher at IBEC, will lead one of the two projects selected in the 2024 call for proposals from the Pasqual Maragall Research Programme, which is dedicated to funding research into Alzheimer’s disease and other neurodegenerative conditions. IBEC also celebrates the participation of Jordi Duran, an associate researcher from the Molecular and Cellular Neurobiotechnology group, who will collaborate on the second selected project.

IBEC, one of the centres selected by the Pasqual Maragall Foundation for its research grants

Amaya Hernández-Vega, a senior researcher at IBEC, will lead one of the two projects selected in the 2024 call for proposals from the Pasqual Maragall Research Programme, which is dedicated to funding research into Alzheimer’s disease and other neurodegenerative conditions. IBEC also celebrates the participation of Jordi Duran, an associate researcher from the Molecular and Cellular Neurobiotechnology group, who will collaborate on the second selected project.

An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.

Scientists reverse Alzheimer’s in mice using nanoparticles

An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.

1 2 3 4

Jobs